LYTIR

Company · GKOS

Glaukos Corporation

Name as listed on its exchange; filed with the SEC as GLAUKOS Corp.

Nasdaq's symbol directory lists GKOS on the New York Stock Exchange as “Glaukos Corporation Common Stock”.

In the 12 months to Nov 19, 2026: insiders sold on 17 occasions ($45.7M); 9 planned-sale notices; 1 filing by holders of 5% or more; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 55, No. 14

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $45.7M in total.Jun: Insider sales $201KJul: Insider sales $4.8MAug: Insider sales $17.3MSep: Insider sales $492KOct: Insider sales $10.9MNov: Insider sales $11.9MDecJanFebMarAprMayJunJulAugSepOctNov$17.3M
Insider purchases above the line: $0Insider sales below: $45.7M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Gilliam Joseph E, PRESIDENT & COO sold on 3 days 2 of them under a 10b5-1 plan latest Nov 16, 2026 sold $22.1M
  2. Navratil Tomas, CHIEF DEVELOPMENT OFFICER sold on 7 days 5 of them under a 10b5-1 plan latest Oct 30, 2026 sold $14.1M
  3. Thurman Alex R., SVP & CHIEF FINANCIAL OFFICER sold on 4 days all under a 10b5-1 plan latest Aug 7, 2026 sold $8.3M
  4. Kliman Gilbert H sold on 2 days latest Nov 4, 2026 sold $1.1M
  5. WEN LEANA sold on 1 day latest Jul 31, 2026 sold $88K
Every trade (17)
  1. SELLGilliam Joseph E, PRESIDENT & COO sold Nov 16, 2026 861 shares 10b5-1 plan (scheduled) filing $215K
  2. SELLGilliam Joseph E, PRESIDENT & COO sold Nov 12, 2026 44,917 shares 6 legs combined 10b5-1 plan (scheduled) filing $11.1M
  3. SELLKliman Gilbert H sold Nov 4, 2026 2,500 shares filing $632K
  4. SELLNavratil Tomas, CHIEF DEVELOPMENT OFFICER sold Oct 30, 2026 44,436 shares 4 legs combined filing $10.6M
  5. SELLNavratil Tomas, CHIEF DEVELOPMENT OFFICER sold Oct 5, 2026 1,527 shares 3 legs combined 10b5-1 plan (scheduled) filing $251K
  6. SELLNavratil Tomas, CHIEF DEVELOPMENT OFFICER sold Sep 25, 2026 1,615 shares 4 legs combined 10b5-1 plan (scheduled) filing $249K
  7. SELLNavratil Tomas, CHIEF DEVELOPMENT OFFICER sold Sep 16, 2026 1,457 shares 7 legs combined 10b5-1 plan (scheduled) filing $243K
  8. SELLNavratil Tomas, CHIEF DEVELOPMENT OFFICER sold Aug 28, 2026 13,744 shares 3 legs combined filing $2.5M
  9. SELLKliman Gilbert H sold Aug 19, 2026 2,500 shares filing $475K
  10. SELLGilliam Joseph E, PRESIDENT & COO sold Aug 11, 2026 60,000 shares 2 legs combined filing $10.8M
  11. SELLThurman Alex R., SVP & CHIEF FINANCIAL OFFICER sold Aug 7, 2026 20,000 shares 10b5-1 plan (scheduled) filing $3.6M
  12. SELLWEN LEANA sold Jul 31, 2026 525 shares filing $88K
  13. SELLThurman Alex R., SVP & CHIEF FINANCIAL OFFICER sold Jul 16, 2026 10,000 shares 10b5-1 plan (scheduled) filing $1.6M
  14. SELLThurman Alex R., SVP & CHIEF FINANCIAL OFFICER sold Jul 9, 2026 10,000 shares 10b5-1 plan (scheduled) filing $1.6M
  15. SELLThurman Alex R., SVP & CHIEF FINANCIAL OFFICER sold Jul 6, 2026 10,000 shares 10b5-1 plan (scheduled) filing $1.5M
  16. SELLNavratil Tomas, CHIEF DEVELOPMENT OFFICER sold Jul 1, 2026 716 shares 10b5-1 plan (scheduled) filing $100K
  17. SELLNavratil Tomas, CHIEF DEVELOPMENT OFFICER sold Jun 16, 2026 1,537 shares 10b5-1 plan (scheduled) filing $201K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Burns Thomas William filed Nov 18, 2026 Officer 180,000 shares planned sale date 11/18/2026 filing $44.2M
  2. Thurman Alex R. filed Nov 18, 2026 Officer 15,000 shares planned sale date 11/18/2026 filing $3.7M
  3. Gilliam Joseph E filed Nov 16, 2026 Officer 861 shares planned sale date 11/16/2026 filing $215K
  4. Gilliam Joseph E filed Nov 12, 2026 Officer 44,917 shares planned sale date 11/12/2026 filing $11.1M
  5. Kliman Gilbert H filed Nov 4, 2026 Director 2,500 shares planned sale date 11/04/2026 filing $632K
  6. Navratil Tomas filed Oct 30, 2026 Officer 44,436 shares planned sale date 10/30/2026 filing $10.6M
  7. Navratil Tomas filed Oct 5, 2026 Officer 1,527 shares planned sale date 10/05/2026 filing $251K
  8. Navratil Tomas filed Sep 25, 2026 Officer 1,615 shares planned sale date 09/25/2026 filing $249K
  9. Navratil Tomas filed Sep 16, 2026 Officer 1,457 shares planned sale date 09/16/2026 filing $243K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. JANUS HENDERSON GROUP Ltd. filed Nov 16, 2026 Schedule 13G/A passive filing 7.9%

Executive branch · OGE Form 278-T

Reported by the President

3 confirmed trades on scanned reports whose security name matches this company's own filed name exactly (letter case, punctuation and Inc/Corp-style endings aside). All of Donald J. Trump's reports

  1. Sale: GLAUKOS CORP Jul 29, 2026 reported Sep 8, 2026 President Donald J. Trump Periodic Transaction Report 09.08.26 $50,001 – $100,000
  2. Purchase: GLAUKOS CORP Jun 15, 2026 reported Aug 12, 2026 President Donald J. Trump Periodic Transaction Report 08.12.26 $1,001 – $15,000
  3. Sale: GLAUKOS CORP May 15, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (2) $15,001 – $50,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Regulation FD disclosure filing Nov 6, 2026
  2. Results of operations and financial condition; Regulation FD disclosure filing Oct 28, 2026

Lobbying · Senate LDA reports

Lobbying filed

3 quarterly lobbying reports for 2026 naming Glaukos Corporation as the client: 1 filed by the company itself, 2 by outside firms it hired. Each line is one report as filed; an amended report is a line of its own. An outside firm states what the company paid it; the company's own report states its whole lobbying spend, which can include those fees, so the lines are not added up. Reports are collected in batches and a quarter can be missing here; the full record is at lda.gov.

  1. The company itself Q1 2026 filing $280K
  2. JEFFREY J. KIMBELL & ASSOCIATES, INC. Q1 2026 filing $20K
  3. THORN RUN PARTNERS Q1 2026 filing $20K

Federal contracts · USAspending.gov

Federal contracts

1 contract award first obligated in the last 12 months to the company or a subsidiary it lists in its 10-K, $21K in total obligated as USAspending.gov lists each award when Lytir last read it. Largest first.

  1. Department of Veterans Affairs Jan 8, 2026 to GLAUKOS CORPORATION award $21K

Sources: SEC EDGAR (Forms 4, 144 and 8-K), Senate LDA lobbying reports, USAspending.gov, OGE Form 278-T reports on whitehouse.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.